Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

9.34
Delayed Data
As of May 28
 -0.02 / -0.21%
Today’s Change
2.65
Today|||52-Week Range
16.87
-23.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization121.0K121.0K136.0K160.0K
 
 
 
 
 
 
Operating ExpensesGross Income-121.0K-121.0K-136.0K-160.0K
 
 
 
 
 
General Expenses15.7M15.9M21.5M19.3M
 
 
 
 
 
Research And Development12.3M12.3M16.4M15.2M
 
 
 
 
 
Total Operating Expenses15.8M16.0M21.7M19.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.8M-16.0M-21.7M-19.5M
 
 
 
 
 
Interest Expense On Debt8.0K4.0K13.0K16.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.7M-15.9M-21.6M-19.3M
 
 
 
 
 
Income Taxes0.00-260.0K0.00-70.0K
 
 
 
Net Income-15.7M-15.7M-21.6M-19.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS97.0M99.0M100.6M111.2M
 
 
 
 
 
Shares To Calculate EPS Diluted97.0M99.0M100.6M111.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.16-$0.21-$0.17
 
 
 
 
 
EPS Diluted-$0.16-$0.16-$0.21-$0.17
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account